hu14.18-IL2
Showing 26 - 50 of >10,000
Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)
Not yet recruiting
- Gastrooesophageal Cancer
- Trastuzumab deruxtecan
-
Southampton, Hampshire, United Kingdom
- +16 more
Jul 27, 2023
Pretreatment Anti-Therapeutic Antibodies in Patients Treated
Completed
- Ewing Family of Tumors
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Nov 4, 2020
ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective
Active, not recruiting
- Iron-Deficiency Anemia
- Iron-Deficiency
- Iron isomaltoside 1000
-
Basel, Switzerland
- +20 more
Nov 4, 2022
Nalbuphine, Idiopathic Pulmonary Fibrosis, Cough Trial in United Kingdom (Nalbuphine ER, Placebo oral tablet)
Completed
- Nalbuphine
- +2 more
- Nalbuphine ER
- Placebo oral tablet
-
Antrim, Northern Ireland, United Kingdom
- +14 more
Oct 3, 2022
MDS (MDS) Trial in United Kingdom (Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol)
Recruiting
- Myelodysplastic Syndromes (MDS)
- Sodium Valproate, Bezafibrate, Medroxyprogesterone
- Danazol
-
Dudley, England, United Kingdom
- +7 more
Aug 12, 2022
Wounds and Injuries, Venous Leg Ulcer, Infection Trial in United Kingdom (DURAFIBER Ag)
Completed
- Wounds and Injuries
- +2 more
- DURAFIBER Ag
-
Hull, East Yorkshire, United Kingdom
- +6 more
Feb 28, 2022
HPV Infections, Cervical Cancer Stage IIa, Vaginal Cancer Trial in Mianyang (2-doses Group among 9-14 years, 3-doses Group among
Recruiting
- HPV Infections
- +6 more
- 2-doses Group among 9-14 years
- +2 more
-
Mianyang, Sichuan, ChinaCenter for Disease Control and Prevention
Feb 23, 2022
Previously Untreated Acute Myeloid Leukemia Trial in United States (biological, other, drug)
Recruiting
- Previously Untreated Acute Myeloid Leukemia
- Samalizumab (BAML-16-001-S1)
- +32 more
-
Phoenix, Arizona
- +18 more
Oct 17, 2022
IgA Nephropathy Trial in United States (Telitacicept 160mg, Telitacicept 240mg, Placebo)
Recruiting
- IgA Nephropathy
- Telitacicept 160mg
- +2 more
-
Los Angeles, California
- +15 more
Feb 7, 2022
Plaque Psoriasis Trial in Italy, Spain (Tildrakizumab 100 mg Solution for Injection)
Completed
- Plaque Psoriasis
- Tildrakizumab 100 mg Solution for Injection
-
Ancona, Italy
- +38 more
Feb 9, 2022
Atopic Dermatitis Trial in Germany, Poland (Lebrikizumab)
Recruiting
- Atopic Dermatitis
- Lebrikizumab
-
Darmstadt, Hessen, Germany
- +31 more
Jun 21, 2023
Oropharyngeal Cancer Trial in United Kingdom (Cisplatin, Durvalumab, Radiotherapy)
Recruiting
- Oropharyngeal Cancer
- Cisplatin
- +3 more
-
Exeter, Devon, United Kingdom
- +32 more
Nov 29, 2021
Breast Cancer, Estrogen Receptor Positive Tumor, HER2-positive Breast Cancer Trial in Worldwide (Paclitaxel, Trastuzumab,
Active, not recruiting
- Breast Cancer
- +2 more
- Paclitaxel
- +4 more
-
Brasschaat, Belgium
- +53 more
Nov 29, 2022
Head Neck Cancer Trial in United Kingdom (recombinant thyroid-stimulating hormone, Radiodine ablation without rhTSH)
Active, not recruiting
- Head and Neck Cancer
- recombinant thyroid-stimulating hormone
- Radiodine ablation without rhTSH
-
Brighton, England, United Kingdom
- +24 more
Oct 13, 2021
COVID-19, Influenza Trial in Quzhou (Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose
Completed
- COVID-19
- Influenza
- Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.
- Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 14.
-
Quzhou, Zhejiang, ChinaKaihua county Center for Disease Control and Prevention
Jul 23, 2021
Melanoma Trial in Groningen (IL2-PET scan, Tumor biopsy, CT scan)
Terminated
- Melanoma
- IL2-PET scan
- +3 more
-
Groningen, NetherlandsUniversity Medical Center Groningen
Mar 19, 2020
Moderate to Severe Plaque Psoriasis Trial in El Salvador, United States (Placebo, SCD-044_Dose 1, SCD-044_Dose 2)
Recruiting
- Moderate to Severe Plaque Psoriasis
- Placebo
- +3 more
-
Yuma, Arizona
- +19 more
Aug 26, 2022
Generalized Myasthenia Gravis Trial in Worldwide (efgartigimod PH20 SC)
Active, not recruiting
- Generalized Myasthenia Gravis
- efgartigimod PH20 SC
-
Carlsbad, California
- +46 more
Jul 5, 2022
Presbyopia Trial in United States (Phentolamine Ophthalmic Solution 0.75%, Pilocarpine, Placebo)
Completed
- Presbyopia
- Phentolamine Ophthalmic Solution 0.75%
- +2 more
-
Laguna Hills, California
- +16 more
Jun 20, 2022
Glioma Glioblastoma Multiforme Trial in United Kingdom (Standard of Care, Additional pre- and intra-operative imaging)
Recruiting
- Glioma Glioblastoma Multiforme
- Standard of Care
- Additional pre- and intra-operative imaging
-
Birmingham, United Kingdom
- +23 more
May 26, 2022
NSCLC Trial in Worldwide (Nivolumab)
Completed
- Non-Small Cell Lung Cancer
-
Wels, Oberösterreich, Austria
- +89 more
Oct 17, 2022